[대역어] 모델링
[용어속성] Term

Effectiveness of the BNT162b2 (Pfizer-BioNTech) and the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccines for reducing susceptibility to infection with the Delta variant (B.1.617.2) of SARS-CoV-2

BNT162b2(화이자-바이오엔텍) 및 ChAdOx1 nCoV-19(옥스포드-아스트라제네카) 백신의 SARS-CoV-2 델타 변이형(B.1.617.2) 감염에 대한 감수성 감소 효과

Article